Skip to main content
. 2017 Dec 28;50(4):1238–1251. doi: 10.4143/crt.2017.534

Fig. 1.

Fig. 1.

Immunohistochemistry (IHC) analysis of primary uveal melanomas without (A) and with BRCA1 associated protein-1 (BAP1) expression (B) (×400). Analysis of recurrence-free survival (RFS, defined as the time from uveal melanoma diagnosis to recurrence) according to BAP1 expression (C). Analysis of overall survival from distant recurrence to death (OS2) according to BAP1 expression in metastatic tissues (D). CI, confidence interval; N/A, not available.